Exopharm is presenting a scientific poster at the 2018 annual conference of the International Society for Extracellular Vesicles (ISEV) together with collaboration partners from the Royal Women’s Hospital in Melbourne, Australia and the California-based nanoparticle analytics start-up Spectradyne LLC. ISEV2018, which is taking place in Barcelona from 2-6 May, is the premier international conference covering the latest science and research in extracellular vesicles and exosomes.

Microfluidic Resistive Pulse Sensing (MRPS) validated as a rapid and practical method for evaluating EV enrichment techniques
Jean-Luc Fraikin1, Jancy Johnson2,4, Ian E. Dixon2,3 Bill Kalionis4, Gregor F. Lichtfuss2,3
1Spectradyne LLC, 23875 Madison St. Suite A, Torrance CA, USA
2Exopharm Pty Ltd, Melbourne, Australia
3Altnia Group, Melbourne, Australia
4Pregnancy Research Center, Department of Maternal-Fetal Medicine, The Royal Women’s Hospital, Parkville, Australia

References
Industry Poster – IP09, Abstract published in
Kathy Baumer & Juan M. Falcon-Perez (2018) ISEV2018 abstract book, Journal of Extracellular Vesicles, 7:sup1, DOI: 10.1080/20013078.2018.1461450

Link to ISEV2018 Abstract book: https://www.tandfonline.com/doi/full/10.1080/20013078.2018.1461450